98 Recruiting Studies Using Methotrexate
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Methotrexate
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax and a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed B Cell Acute Lymphoblastic Leukemia
📍 City of Hope Medical Center — Duarte, California
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
📍 Children's Hospital of Alabama — Birmingham, Alabama
Adult T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Primary Central Nervous System Lymphoma
View Study & Checklist ➔Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
📍 City of Hope — Goodyear, Arizona
Multiple Myeloma
View Study & Checklist ➔Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
📍 University of Colorado — Aurora, Colorado
Hematologic Diseases
View Study & Checklist ➔Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Primary Myelofibrosis
View Study & Checklist ➔A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
📍 Arizona Arthritis & Rheumatology Associates, P.C. ( Site 1018) — Glendale, Arizona
Arthritis, Rheumatoid
View Study & Checklist ➔A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
📍 Indiana University — Bloomington, Indiana
Urothelial Carcinoma
View Study & Checklist ➔Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Mantle Cell Lymphoma
View Study & Checklist ➔Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
📍 Mount Sinai Hospital — New York, New York
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)
📍 Clinica de la Costa — Barranquilla,
Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease Severity
View Study & Checklist ➔Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
Blastoid Variant Mantle Cell Lymphoma
View Study & Checklist ➔Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
📍 Lucille Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California
Malignant Rhabdoid Tumor
View Study & Checklist ➔Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent B Acute Lymphoblastic Leukemia
View Study & Checklist ➔LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
Central Nervous System Lymphoma
View Study & Checklist ➔Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
📍 Rady Children's Hospital-San Diego — San Diego, California
Acute Leukemia of Ambiguous Lineage in Relapse
View Study & Checklist ➔A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Leukemia
View Study & Checklist ➔Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
📍 University of Illinois at Chicago — Chicago, Illinois
Acute Myeloid Leukemia
View Study & Checklist ➔A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Severe Aplastic Anemia
View Study & Checklist ➔Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib, and Rituximab (TEDDI-R) in Aggressive B-cell Lymphomas With Secondary Involvement of the Central Nervous System (CNS)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Central Nervous System Lymphoma
View Study & Checklist ➔Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
📍 Boston Children's Hospital — Boston, Massachusetts
Acute Lymphoblastic Leukemia, Pediatric
View Study & Checklist ➔LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
📍 Children's of Alabama — Birmingham, Alabama
Langerhans Cell Histiocytosis
View Study & Checklist ➔Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma
📍 Lucile Packard Children's Hospital Stanford University — Palo Alto, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Premedication to Reduce Amivantamab Associated Infusion Related Reactions
📍 Compassionate Cancer Care — Fountain Valley, California
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
📍 Children's Hospital Los Angeles — Los Angeles, California
ALL, Childhood
View Study & Checklist ➔A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham — Birmingham, Alabama
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
View Study & Checklist ➔Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia
📍 OHSU Knight Cancer Institute — Portland, Oregon
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I
📍 Children's Hospital Los Angeles — Los Angeles, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Refractory Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate
📍 Local Institution - 0036 — Fullerton, California
Rheumatoid Arthritis
View Study & Checklist ➔Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
📍 University Of Colorado — Aurora, Colorado
Lymphoma
View Study & Checklist ➔Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
📍 University of Chicago Medical Center — Chicago, Illinois
Acute Lymphoblastic Leukemia
View Study & Checklist ➔CHronic Nonbacterial Osteomyelitis International Registry
📍 Seattle Children's Hospital — Seattle, Washington
Chronic Nonbacterial Osteomyelitis
View Study & Checklist ➔Immune Modulation During Palynziq® Treatment in Adults (IMPALA)
📍 UCLA Dept. of Human Genetics — Los Angeles, California
Phenylketonuria
View Study & Checklist ➔A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
📍 University of Alabama at Birmingham — Birmingham, Alabama
Uncontrolled Gout
View Study & Checklist ➔Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
📍 Novant Health Presbyterian Hemby Children's Hospital — Charlotte, North Carolina
Acute Lymphoblastic Leukemia
View Study & Checklist ➔MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial
📍 Ruttenberg Treatment Center — New York, New York
Polycythemia Vera (PV)
View Study & Checklist ➔TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
📍 Phoenix Children's Hospital — Phoenix, Arizona
Lymphoblastic Leukemia
View Study & Checklist ➔Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
📍 Brigham and Women's Hospital — Boston, Massachusetts
Lymphoma
View Study & Checklist ➔A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)
📍 Applied Research Center of Arkansas — Little Rock, Arkansas
Gout
View Study & Checklist ➔Prevention of ProliFerative Vitreoretinopathy with Intravitreal MethotreXate in Primary Retinal DEtachment Repair (FIXER) Trial
📍 Cincinnati Eye Institute — Cincinnati, Ohio
Proliferative Vitreoretinopathy
View Study & Checklist ➔An Open-Label Study of Effectiveness of Immunomodulatory Medications for Patients With Relapsing Polychondritis
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Relapsing Polychondritis
View Study & Checklist ➔Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Leukemia
View Study & Checklist ➔Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
📍 Lucille Packard Children's Hospital Stanford — Palo Alto, California
Medulloblastoma
View Study & Checklist ➔Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
📍 Rady Children's Hospital — San Diego, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Acute Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
📍 Rady Children's Hospital — San Diego, California
T-cell Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
Non-hodgkin Lymphoma
View Study & Checklist ➔Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
📍 University of Alabama — Birmingham, Alabama
NK-Cell Lymphoma
View Study & Checklist ➔Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic Leukemia
📍 Northside Hospital — Atlanta, Georgia
Acute Lymphoblastic Leukemia
View Study & Checklist ➔A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
Down Syndrome
View Study & Checklist ➔Venetoclax Basket Trial for High Risk Hematologic Malignancies
📍 University of California San Francisco-Benioff Children's Hospital — San Francisco, California
Myelodysplastic Syndromes, de Novo
View Study & Checklist ➔Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
📍 Rady Children's Hospital — San Diego, California
Refractory Acute Myeloid Leukemia
View Study & Checklist ➔Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 M D Anderson Cancer Center — Houston, Texas
T Acute Lymphoblastic Leukemia
View Study & Checklist ➔Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
View Study & Checklist ➔Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
📍 St. Joseph's Children's Hospital — Tampa, Florida
Osteosarcoma
View Study & Checklist ➔Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)
📍 Research Site — Chermside,
Urinary Bladder Neoplasms
View Study & Checklist ➔Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
View Study & Checklist ➔Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
📍 City of Hope at Phoenix — Phoenix, Arizona
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
View Study & Checklist ➔A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
📍 Children's Hospital of Alabama — Birmingham, Alabama
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
📍 City of Hope Medical Center — Duarte, California
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
📍 M D Anderson Cancer Center — Houston, Texas
Blastic Plasmacytoid Dendritic Cell Neoplasm
View Study & Checklist ➔Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
📍 Children's Hospital Los Angeles — Los Angeles, California
Hematologic Malignancy
View Study & Checklist ➔Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
📍 University of Chicago Medical Center — Chicago, Illinois
Lymphoblastic Leukemia
View Study & Checklist ➔A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Osteosarcoma
View Study & Checklist ➔Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
B Acute Lymphoblastic Leukemia
View Study & Checklist ➔Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
📍 Children's Hospital of Los Angeles — Los Angeles, California
Acute Biphenotypic Leukemia
View Study & Checklist ➔Cardiac Sarcoidosis Randomized Trial
📍 Yale-New Haven Hospital — New Haven, Connecticut
Cardiac Sarcoidosis
View Study & Checklist ➔BRE-08 Phase II Study of CMC Regimen for Early Stage Breast Cancer
📍 University of Illinois — Chicago, Illinois
Breast Cancer
View Study & Checklist ➔Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
📍 University of Nebraska Medical Center — Omaha, Nebraska
Rheumatoid Arthritis
View Study & Checklist ➔A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
📍 Stanford Cancer Center — Palo Alto, California
Graft-versus-host Disease (GVHD)
View Study & Checklist ➔A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
📍 Children's Hospital of Alabama — Birmingham, Alabama
Recurrent Childhood Acute Myeloid Leukemia
View Study & Checklist ➔Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
📍 Kingman Regional Medical Center — Kingman, Arizona
Renal Pelvis and Ureter Urothelial Carcinoma
View Study & Checklist ➔Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Myelodysplastic/Myeloproliferative Neoplasm
View Study & Checklist ➔Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
📍 OHSU Knight Cancer Institute — Portland, Oregon
Hematopoietic and Lymphatic System Neoplasm
View Study & Checklist ➔Testing the Addition of Lenalidomide and Nivolumab to the Usual Treatment for Primary CNS Lymphoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
View Study & Checklist ➔Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma
📍 University of Miami — Miami, Florida
CNS Lymphoma
View Study & Checklist ➔ALL Backbone in AYAs
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Acute Lymphoblastic Leukemia
View Study & Checklist ➔Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Metastatic Oral Cavity Carcinoma
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
📍 Moffitt Cancer Center — Tampa, Florida
Acute Leukemia
View Study & Checklist ➔Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Leukemia of Ambiguous Lineage
View Study & Checklist ➔